Atlas Trials

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

Clinical trial NCT07610395 · RECRUITING

Trial details

NCT number
NCT07610395
Sponsor
Altesa Biosciences, Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Rhinovirus Infection
Start date
2026-05-01
Primary completion
2027-11-15
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.